@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G7KXQWSR-5
  skos:prefLabel "biosynthèse (Qualificatif)"@fr, "biosynthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Z9TSGBXH-4
  skos:prefLabel "génétique (Qualificatif)"@fr, "genetics (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-T2TS0S41-N
  skos:prefLabel "ultrastructure (Qualifier)"@en, "ultrastructure (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-LXTXZX7Q-M
  skos:prefLabel "Benzylamine Oxidase"@en, "Benzylamine oxidase"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-W42MV4L9-M .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CJXMKG5Q-F
  skos:prefLabel "deficiency (Qualifier)"@en, "déficit (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-DCS9TGQP-F
  skos:prefLabel "Oxidoreductases Acting on CH-NH2 Group Donors"@en, "Oxidoreductases acting on CH-NH2 group donors"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-W42MV4L9-M .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-N2WP45CN-V
  skos:prefLabel "drug effects (Qualifier)"@en, "effets des médicaments et des substances chimiques (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WZF2ZR3L-B
  skos:prefLabel "physiology (Qualifier)"@en, "physiologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W42MV4L9-M
  mesh:allowableQualifier jvr:-Q3979798-W, jvr:-NFTHND7Q-8, jvr:-T9HQD7ST-J, jvr:-S0CS1X5R-5, jvr:-NB0XHT3S-N, jvr:-G7KXQWSR-5, jvr:-N2WP45CN-V, jvr:-G30ZJ446-J, jvr:-NKM836P1-M, jvr:-BT300B3G-Q, jvr:-NHL3D2X0-S, jvr:-T2TS0S41-N, jvr:-HQRFT0C6-B, jvr:-CB30NGKB-3, jvr:-XV06LPML-W, jvr:-WZF2ZR3L-B, jvr:-R3QWLHRG-V, jvr:-WK5F724J-1, jvr:-L6C0XPHT-4, jvr:-THHNVC7V-3, jvr:-W6SQV79N-S, jvr:-TJHVZCRZ-0, jvr:-Z9TSGBXH-4, jvr:-SBNWSM1T-R, jvr:-H7K65Q8S-Z, jvr:-FWD2BGQ0-9, jvr:-CJXMKG5Q-F, jvr:-D0F21513-5 ;
  dc:established "1963-01-01"^^xsd:date ;
  skos:prefLabel "Monoamine oxidase"@fr, "Monoamine Oxidase"@en ;
  skos:hiddenLabel "Monoamine Oxidase B"@en, "Monoamine Oxidase A"@en, "Type A Monoamine Oxidase"@en, "MAO-B"@en, "Type B Monoamine Oxidase"@en, "EC 1.4.3.4"@fr, "EC 1.4.3.4"@en, "MAO-A"@en ;
  skos:altLabel "Tyramine Oxidase"@en, "Tyramine oxidase"@fr, "Amine Oxidase (Flavin-Containing)"@en, "Amine:oxygen oxidoreductase (deaminating) (flavin-containing)"@fr, "Amine:oxygen oxidoreductase (deaminating) (flavin-containing)"@en, "9001-66-5 (CAS RN)"@fr, "9001-66-5 (CAS RN)"@en, "Adrenaline oxidase"@fr, "MAO"@fr, "MAO"@en, "Tyraminase"@fr ;
  skos:definition "An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4."@en ;
  skos:inScheme jvr: ;
  skos:broader jvr:-DCS9TGQP-F ;
  dc:modified "2005-06-30"^^xsd:date ;
  skos:narrower jvr:-LXTXZX7Q-M ;
  a skos:Concept, mesh:Descriptor ;
  dc:created "1999-01-01"^^xsd:date ;
  mesh:registryNumber "EC 1.4.3.4" ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D008995> .

